Live tape
Top 8, mentions 7d15,917MSFT3,128 mentions▲ +0.09GOOGL2,202 mentions▲ +0.05AAPL2,155 mentions▲ +0.07META2,102 mentions▲ +0.04SNDK1,871 mentions▲ +0.07NVDA1,613 mentions▲ +0.07SPCX1,592 mentions▲ +0.06AMZN1,254 mentions▲ +0.08

Equity · Healthcare

BEAM

Beam Therapeutics Inc. · NasdaqGS

$26.27 +4.83% 1D Finazon · prior-day close · Jul 28, 2026
Price · Chart Chart by TradingView

The chart above plots the price of BEAM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $30.09 on 4 May 2026 through $26.27 on 28 July 2026. Finazon · prior-day close.

Market cap $2.7B
52-week range $16.00 – $37.96
Avg volume 472.4K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

BEAM insider trades

SEC Form 4

BEAM has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 27 October 2025.

Date Insider Type Shares Value
27 Oct 2025 FMR LLC Sell 459 $12K
02 Oct 2025 Evans John M. CEO Sell 25,000 $616K
01 Oct 2025 Evans John M. CEO Sell 25,000 $613K
01 Oct 2025 Bellon Christine Chief Legal Officer Sell 373 $9K
01 Oct 2025 Cavanagh Bethany J SVP, Finance and Treasurer Sell 467 $11K
30 Jul 2025 FMR LLC Sell 48,374 $992K
03 Jul 2025 Simon Amy Chief Medical Officer Sell 876 $18K
01 Jul 2025 Simon Amy Chief Medical Officer Sell 374 $6K
Compensation mechanics (3 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
06 Oct 2025 FMR LLC Gift 1,232,434
02 Oct 2025 Evans John M. CEO Option exercise 25,000 $17K
01 Oct 2025 Evans John M. CEO Option exercise 25,000 $17K

BEAM reported financials

SEC EDGAR XBRL

BEAM reported revenue of $139.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$80.0M.

Figure Reported Period
Revenue $139.7M 31 Dec 2025 fiscal year
Net income −$80.0M 31 Dec 2025 fiscal year
Diluted EPS −$0.81 31 Dec 2025 fiscal year
Total assets $1.5B 31 Mar 2026 at period end
Total equity $1.2B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

BEAM earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.91
31 Dec 2025 FY 2025 $-0.81
30 Sep 2025 Q3 2025 $-1.10
30 Jun 2025 Q2 2025 $-1.00

Reported figures & scheduled dates · SEC EDGAR filings

BEAM institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a BEAM position for the quarter ended 31 Mar 2026 — a combined $353.7M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) −2.7% shares 12,133,433 $289.1M
Two Sigma Investments Held (±25%) +8.1% shares 1,210,853 $28.9M
Citadel Advisors Added +106.9% shares 528,970 $12.6M
Renaissance Technologies Added +228.2% shares 513,578 $12.2M
Man Group New position 231,994 $5.5M
Marshall Wace Trimmed −85.3% shares 139,241 $3.3M
Tudor Investment Corp Added +191.9% shares 47,310 $1.1M
Millennium Management Trimmed −92.6% shares 22,234 $530K
AQR Capital Management Held (±25%) +18.8% shares 15,692 $374K

Source: SEC EDGAR 13F filings

BEAM fails-to-deliver

SEC CNS data

On 30 Jun 2026, 3,043 shares of BEAM failed to deliver (about $106K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Jun 2026 3,043 $106K 0.003%
29 Jun 2026 26,787 $932K 0.026%
22 Jun 2026 500 $17K <0.001%
17 Jun 2026 32 $992 <0.001%

Source: SEC fails-to-deliver (CNS) data